Burcon NutraScience Corporation
BU.TO · TSX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | CA$14,857 | CA$1,408,240 | CA$1,174,273 | CA$5,168,789 |
| - Cash | CA$7,276 | CA$4,197 | CA$1,457 | CA$7,001 |
| + Debt | CA$22,396 | CA$6,666 | CA$5,171 | CA$73 |
| Enterprise Value | CA$29,977 | CA$1,410,708 | CA$1,177,987 | CA$5,161,861 |
| Revenue | CA$381 | CA$184 | CA$364 | CA$171 |
| % Growth | 106.9% | -49.3% | 112.2% | – |
| Gross Profit | -CA$871 | CA$184 | CA$364 | CA$171 |
| % Margin | -228.3% | 100% | 100% | 100% |
| EBITDA | -CA$7,435 | -CA$6,231 | -CA$18,904 | -CA$9,924 |
| % Margin | -1,949.3% | -3,380% | -5,194.7% | -5,787.8% |
| Net Income | -CA$8,265 | -CA$7,446 | -CA$25,364 | -CA$10,258 |
| % Margin | -2,167% | -4,039% | -6,969.9% | -5,982.6% |
| EPS Diluted | -1.06 | -0.031 | -0.11 | -0.047 |
| % Growth | -3,364.1% | 72.2% | -133.1% | – |
| Operating Cash Flow | -CA$5,513 | -CA$5,777 | -CA$6,016 | -CA$5,914 |
| Capital Expenditures | -CA$303 | -CA$127 | -CA$360 | -CA$1,269 |
| Free Cash Flow | -CA$5,816 | -CA$5,904 | -CA$6,375 | -CA$7,182 |